BioCentury | May 16, 2016
Clinical News

ITCA 650: Phase III data

...BioCentury, Nov. 17, 2014). Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Aug 24, 2015
Clinical News

ITCA 650: Phase III data

...BioCentury, Nov. 17, 2014). Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Jun 15, 2015
Clinical News

ITCA 650: Additional Phase III data

...BioCentury, Nov. 17, 2014). Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | May 11, 2015
Clinical News

Ionsys fentanyl iontophoretic transdermal system regulatory update

...next quarter. The Medicines Co. has exclusive, worldwide rights to Ionsys from Johnson & Johnson’s Alza Corp....
BioCentury | Oct 6, 2014
Clinical News

ITCA 650: Additional Phase III data

...650 in early 2016. Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Oct 6, 2014
Clinical News

ITCA 650: Phase III data

...650 in early 2016. Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Jun 23, 2014
Clinical News

ITCA 650: Interim Phase III data

...are expected in September. Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Apr 7, 2014
Finance

All in for Type II

...ideal risk-reward profile," he said. Intarcia has a license to use the Duros device from Alza Corp....
BioCentury | Apr 2, 2014
Financial News

Intarcia raises $200 million

...implantable Duros osmotic mini-pump. Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Mar 24, 2014
Strategy

A Remembrance: The quintessential serial entrepreneur

...major U.S.-based company. In 1968, with Syntex having grown beyond his comfort zone, Alex founded Alza Corp....
...technology ranging from transdermal patches to insertable devices to oral, controlled-release systems. Like many biotechs, Alza...
...location nearby Stanford. I was equally awed by his decision to leave Syntex to found Alza...
Items per page:
1 - 10 of 539
BioCentury | May 16, 2016
Clinical News

ITCA 650: Phase III data

...BioCentury, Nov. 17, 2014). Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Aug 24, 2015
Clinical News

ITCA 650: Phase III data

...BioCentury, Nov. 17, 2014). Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Jun 15, 2015
Clinical News

ITCA 650: Additional Phase III data

...BioCentury, Nov. 17, 2014). Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | May 11, 2015
Clinical News

Ionsys fentanyl iontophoretic transdermal system regulatory update

...next quarter. The Medicines Co. has exclusive, worldwide rights to Ionsys from Johnson & Johnson’s Alza Corp....
BioCentury | Oct 6, 2014
Clinical News

ITCA 650: Additional Phase III data

...650 in early 2016. Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Oct 6, 2014
Clinical News

ITCA 650: Phase III data

...650 in early 2016. Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Jun 23, 2014
Clinical News

ITCA 650: Interim Phase III data

...are expected in September. Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Apr 7, 2014
Finance

All in for Type II

...ideal risk-reward profile," he said. Intarcia has a license to use the Duros device from Alza Corp....
BioCentury | Apr 2, 2014
Financial News

Intarcia raises $200 million

...implantable Duros osmotic mini-pump. Intarcia has a license to use the Duros delivery device from Alza Corp....
BioCentury | Mar 24, 2014
Strategy

A Remembrance: The quintessential serial entrepreneur

...major U.S.-based company. In 1968, with Syntex having grown beyond his comfort zone, Alex founded Alza Corp....
...technology ranging from transdermal patches to insertable devices to oral, controlled-release systems. Like many biotechs, Alza...
...location nearby Stanford. I was equally awed by his decision to leave Syntex to found Alza...
Items per page:
1 - 10 of 539